Stocks and InvestingStocks and Investing
Tue, October 29, 2019
Mon, October 28, 2019
Fri, October 25, 2019
Thu, October 24, 2019
Wed, October 23, 2019

Evan Seigerman Maintained (BIIB) at Sell with Increased Target to $260 on, Oct 23rd, 2019


Published on 2024-10-26 17:13:33 - WOPRAI, Evan Seigerman
  Print publication without navigation


Evan Seigerman of Credit Suisse, Maintained "Biogen Inc." (BIIB) at Sell with Increased Target from $203 to $260 on, Oct 23rd, 2019.

Evan has made no other calls on BIIB in the last 4 months.



There is 1 other peer that has a rating on BIIB. Out of the 1 peers that are also analyzing BIIB, all agrees with Evan's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $250 on, Friday, June 28th, 2019